SPDR S&P China ETF (NYSEARCA:GXC) Trading 1.3% Higher – Still a Buy?

SPDR S&P China ETF (NYSEARCA:GXC) shares rose 1.3% on Tuesday . The company traded as high as $89.13 and last traded at $88.73. 9,309 shares changed hands during mid-day trading, a decline of 67% from the average session volume of 27,958 shares. The stock had previously closed at $87.56.

SPDR S&P China ETF Trading Up 1.3%

The stock has a market cap of $448.09 million, a price-to-earnings ratio of 12.97 and a beta of 0.35. The company has a fifty day simple moving average of $91.52 and a 200-day simple moving average of $95.63.

Institutional Investors Weigh In On SPDR S&P China ETF

A number of large investors have recently made changes to their positions in GXC. Wealthcare Advisory Partners LLC lifted its position in shares of SPDR S&P China ETF by 7.6% in the 2nd quarter. Wealthcare Advisory Partners LLC now owns 33,465 shares of the company’s stock valued at $2,895,000 after acquiring an additional 2,350 shares in the last quarter. CoreCap Advisors LLC grew its position in SPDR S&P China ETF by 10.0% during the 2nd quarter. CoreCap Advisors LLC now owns 3,595 shares of the company’s stock worth $311,000 after purchasing an additional 326 shares in the last quarter. Parallel Advisors LLC grew its position in SPDR S&P China ETF by 12.7% during the 1st quarter. Parallel Advisors LLC now owns 2,670 shares of the company’s stock worth $249,000 after purchasing an additional 300 shares in the last quarter. First Trust Advisors LP raised its stake in SPDR S&P China ETF by 28.1% during the 1st quarter. First Trust Advisors LP now owns 11,193 shares of the company’s stock valued at $1,042,000 after purchasing an additional 2,452 shares during the period. Finally, Assetmark Inc. raised its stake in SPDR S&P China ETF by 0.8% during the 1st quarter. Assetmark Inc. now owns 221,133 shares of the company’s stock valued at $20,592,000 after purchasing an additional 1,660 shares during the period.

About SPDR S&P China ETF

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors. The Index is float adjusted, meaning that only those shares publicly available to investors are included in the Index calculation. The Fund uses a passive management strategy designed to track the price and yield performance of the Index.